Last update Sept. 19, 2016
Very Low Risk
We do not have alternatives for コンドロイチン硫酸エステルナトリウム since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
コンドロイチン硫酸エステルナトリウム is Chondroitin Sulfate Sodium in Japanese.Is written in other languages:
コンドロイチン硫酸エステルナトリウム belongs to this group or family:
Main tradenames from several countries containing コンドロイチン硫酸エステルナトリウム in its composition:
|T½||5 - 15||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Copolymer which is found in nature that is obtained from cartilage of various terrestrial or marine animals and used in the treatment of osteoarthritis.
It is a mucopolysaccharide which is formed by polymers of glycosaminoglycan (GAG) and devoid of toxicity.
It is presented in the human body and breast milk, with the highest concentration in the milk of mothers of preterm babies. (Coppa 2012).
Half concentration of GAG in the milk is contained as chondroitin sulfate with anti-infectious properties; among others, it protects the gastrointestinal tract of infants against infections (Maccari 2016).
Its concentration is not affected by Holder pasteurization method of breast milk.
Changes on the composition of chondroitin sulfate in the milk have been detected in cases of breast cancer.
Because a high molecular weight the passage of significant amounts into milk is highly unlikely.
Its low oral bioavailability hinders the passage from ingested milk to the infant plasma.